All Companies
Ticker RZLT
Below our coverage size floor
You reached the page — here's exactly what RZLT is, and why it's out of scope for now.
What this ticker is
RZLT
Rezolute, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $442.9M
Rezolute, Inc. is a late-stage rare disease company focused on developing therapies to improve outcomes for individuals with hypoglycemia caused by hyperinsulinism, including congenital and tumor forms. Its lead clinical asset, ersodetug, is an intravenously administered human monoclonal antibody that binds to an allosteric site on the insulin receptor in t…
Why we can't analyze it yet
Below business size floor — market cap $452,573,955 is under our $500,000,000 coverage minimum
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
below_coverage